Fig. 3From: Clinical outcomes in 2481 unselected real-world patients treated with a polymer-free sirolimus-eluting stent: 3 years results from the NANO multicenter RegistryCumulative incidence of cardiac death (a), target vessel nonfatal MI (b), clinical driven TLR (c), and ST (d) up to 3 years. TLR, target lesion revascularization; MI, myocardial infarction; ST, stent thrombosisBack to article page